114 related articles for article (PubMed ID: 36680551)
1. Validated HPLC-UV method for quantification of paxalisib, a pan PI3K and mTOR inhibitor in mouse plasma: Application to a pharmacokinetic study in mice.
Zakkula A; Tripathy HK; Bestha RM; Vinod AB; Kiran V; Dittakavi S; Mullangi R
Biomed Chromatogr; 2023 Apr; 37(4):e5587. PubMed ID: 36680551
[TBL] [Abstract][Full Text] [Related]
2. Validated liquid chromatography with tandem mass spectrometry method for determination of paxalisib in mouse plasma: An application to pharmacokinetic study in mice.
A B V; Das A
Biomed Chromatogr; 2023 Aug; 37(8):e5650. PubMed ID: 37070164
[TBL] [Abstract][Full Text] [Related]
3. Validated HPLC method for quantification of copanlisib in mice plasma: application to a pharmacokinetic study.
Zakkula A; Kurakula PK; Dittakavi S; Daram P; Bestha RM; Zainuddin M; Trivedi RK; Mullangi R
ADMET DMPK; 2020; 8(1):113-121. PubMed ID: 35299776
[TBL] [Abstract][Full Text] [Related]
4. Validated HPLC-UV method for simultaneous quantification of phosphatidylinositol 3-kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats.
Siddesh A; Sriram D; Zakkula A; Kumar R; Dittakavi S; Zainuddin M; Trivedi RK; Mullangi R
Biomed Chromatogr; 2021 Apr; 35(4):e5015. PubMed ID: 33125719
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an HPLC Method for Quantification of Filgotinib, a Novel JAK-1 Inhibitor in Mice Plasma: Application to a Pharmacokinetic Study.
Zakkula A; Pulipati S; Dittakavi S; Bestha RM; Zainuddin M; Trivedi RK; Mullangi R
Drug Res (Stuttg); 2020 May; 70(5):233-238. PubMed ID: 32289835
[TBL] [Abstract][Full Text] [Related]
6. Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study.
Zakkula A; Dittakavi S; Maniyar MM; Syed N; Sulochana SP; Zainuddin M; Mullangi R
Biomed Chromatogr; 2019 Nov; 33(11):e4658. PubMed ID: 31325170
[TBL] [Abstract][Full Text] [Related]
7. Validated HPLC Method for Quantification of a Novel Trk Inhibitor, Larotrectinib in Mice Plasma: Application to a Pharmacokinetic Study.
Tripathy HK; Nair Manju SV; Zakkula A; Bestha RM; Dittakavi S; Mullangi R
Drug Res (Stuttg); 2020 Feb; 70(2-03):101-106. PubMed ID: 31931548
[TBL] [Abstract][Full Text] [Related]
8. Preclinical characterization of the absorption and disposition of the brain penetrant PI3K/mTOR inhibitor paxalisib and prediction of its pharmacokinetics and efficacy in human.
Salphati L; Pang J; Alicke B; Plise EG; Cheong J; Jaochico A; Olivero AG; Sampath D; Wong S; Zhang X
Xenobiotica; 2024 Feb; 54(2):64-74. PubMed ID: 38197324
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a RP-HPLC method for the quantitation of tofacitinib in rat plasma and its application to a pharmacokinetic study.
S VK; Dhiman V; Giri KK; Sharma K; Zainuddin M; Mullangi R
Biomed Chromatogr; 2015 Sep; 29(9):1325-9. PubMed ID: 25622797
[TBL] [Abstract][Full Text] [Related]
10. Validated liquid chromatography-tandem mass spectrometry method for simultaneous quantitation of bendamustine and copanlisib in mouse plasma: Application to a pharmacokinetic study in mice.
Tripathy HK; Manju SVN; Bestha RM; Kiran V; Dittakavi S; Mullangi R
Biomed Chromatogr; 2022 Aug; 36(8):e5387. PubMed ID: 35470912
[TBL] [Abstract][Full Text] [Related]
11. RP-HPLC-UV Method for Simultaneous Quantification of Second Generation Non-Steroidal Antiandrogens Along with their Active Metabolites in Mice Plasma: Application to a Pharmacokinetic Study.
Zakkula A; Kiran V; Todmal U; Sulochana SP; Mullangi R
Drug Res (Stuttg); 2019 Oct; 69(10):537-544. PubMed ID: 30536259
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an RP-HPLC method for the quantitation of Orteronel (TAK-700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study.
Kumar A; S VK; Gurav S; Zainuddin M; Dewang P; Kethiri RR; Rajagopal S; Mullangi R
Biomed Chromatogr; 2013 Dec; 27(12):1590-4. PubMed ID: 23788266
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study.
Police A; Gurav S; Dhiman V; Zainuddin M; Bhamidipati RK; Rajagopal S; Mullangi R
Biomed Chromatogr; 2015 Nov; 29(11):1664-9. PubMed ID: 25914381
[TBL] [Abstract][Full Text] [Related]
14. A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma.
AlRabiah H; Kadi AA; Aljohar HI; Attwa MW; Al-Shakliah NS; Attia SM; Mostafa GA
Drug Des Devel Ther; 2020; 14():407-415. PubMed ID: 32095071
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
16. Development of a fully automated on-line solid phase extraction and high-performance liquid chromatography with diode array detection method for the pharmacokinetic evaluation of bavachinin: a study on absolute bioavailability and dose proportionality.
Liu L; Liu KN; Wen YB; Zhang HW; Lu YX; Yin Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():21-8. PubMed ID: 22444438
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography-tandem mass spectrometry method for determination of rivaroxaban in human plasma and its application to a pharmacokinetic study.
Shaikh K; Mungantiwar A; Halde S; Pandita N
Eur J Mass Spectrom (Chichester); 2020 Apr; 26(2):91-105. PubMed ID: 31514543
[TBL] [Abstract][Full Text] [Related]
18. Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats.
Kumar SV; Rudresha G; Gurav S; Zainuddin M; Dewang P; Kethiri RR; Rajagopal S; Mullangi R
Biomed Chromatogr; 2013 Feb; 27(2):203-7. PubMed ID: 22763809
[TBL] [Abstract][Full Text] [Related]
19. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
[TBL] [Abstract][Full Text] [Related]
20. LC-ESI-MS/MS determination of copanlisib, a novel PI3K inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice.
Dittakavi S; Mullangi R
Biomed Chromatogr; 2019 Apr; 33(4):e4460. PubMed ID: 30536684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
